Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Hauben

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Drug Safety|November 27, 2007
Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES)Manfred Hauben, Lester Reich, Charles M Gerrits, et al.
Drug Safety|December 6, 2011
Terminological challenges in safety surveillanceAndrew Bate, Elliot G Brown, Stephen A Goldman, et al.
Drug Safety|August 31, 2023
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative ApproachValentina Giunchi, Michele Fusaroli, Manfred Hauben, et al.
Pharmacoepidemiology and Drug Safety|November 12, 2022
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matchingEric Hung, Manfred Hauben, Henry Essex, et al.
Drug Safety|September 27, 2005
Data mining in pharmacovigilance: the need for a balanced perspectiveManfred Hauben, Vaishali Patadia, Charles Gerrits, et al.
Therapeutic Advances in Drug Safety|June 8, 2017
The impact of database restriction on pharmacovigilance signal detection of selected cancer therapiesManfred Hauben, Eric Hung, Jennifer Wood, et al.
Bioinformatics (Oxford, England)|October 16, 2012
Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databasesKjell Johnson, Cen Guo, Mark Gosink, et al.
Human Vaccines|May 25, 2010
Quantitative signal detection for vaccinesManfred Hauben, David Madigan, Vaishali Patadia, et al.
Drug Safety|November 17, 2010
An experimental investigation of masking in the US FDA adverse event reporting system databaseHsin-wei Wang, Alan M Hochberg, Ronald K Pearson, et al.
Inflammatory Bowel Diseases|June 14, 2022
A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for InterpretationImogen S Stafford, Mark M Gosink, Enrico Mossotto, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Drug Safety|November 27, 2007
Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES)Manfred Hauben, Lester Reich, Charles M Gerrits, et al.
Drug Safety|December 6, 2011
Terminological challenges in safety surveillanceAndrew Bate, Elliot G Brown, Stephen A Goldman, et al.
Drug Safety|August 31, 2023
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative ApproachValentina Giunchi, Michele Fusaroli, Manfred Hauben, et al.
Pharmacoepidemiology and Drug Safety|November 12, 2022
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matchingEric Hung, Manfred Hauben, Henry Essex, et al.
Drug Safety|September 27, 2005
Data mining in pharmacovigilance: the need for a balanced perspectiveManfred Hauben, Vaishali Patadia, Charles Gerrits, et al.
Therapeutic Advances in Drug Safety|June 8, 2017
The impact of database restriction on pharmacovigilance signal detection of selected cancer therapiesManfred Hauben, Eric Hung, Jennifer Wood, et al.
Bioinformatics (Oxford, England)|October 16, 2012
Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databasesKjell Johnson, Cen Guo, Mark Gosink, et al.
Human Vaccines|May 25, 2010
Quantitative signal detection for vaccinesManfred Hauben, David Madigan, Vaishali Patadia, et al.
Drug Safety|November 17, 2010
An experimental investigation of masking in the US FDA adverse event reporting system databaseHsin-wei Wang, Alan M Hochberg, Ronald K Pearson, et al.
Inflammatory Bowel Diseases|June 14, 2022
A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for InterpretationImogen S Stafford, Mark M Gosink, Enrico Mossotto, et al.
Pageof 12